The Journal of Urology
Volume 183, Issue 5 , Pages 1915-1920 , May 2010

Progression of Lower Urinary Tract Symptoms in Older Men: A Community Based Study

  • J. Kellogg Parsons

      Affiliations

    • Division of Urologic Oncology, Moores Comprehensive Cancer Center and Division of Urology, San Diego Veterans Affairs Medical Center, University of California-San Diego, La Jolla, San Francisco, California
    • Corresponding Author InformationCorrespondence: c/o Leslie Parker, Division of Urology, University of Cailifornia-San Diego 200 West Arbor Dr., San Diego, California 92103-8897
    • ,
  • Timothy J. Wilt

      Affiliations

    • Section of General Medicine, Center for Chronic Disease Outcomes Research, Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota
    • ,
  • Patty Y. Wang

      Affiliations

    • Department of Medicine (Bone and Mineral Unit), Oregon Health and Science University, Portland, Oregon
    • ,
  • Elizabeth Barrett-Connor

      Affiliations

    • Department of Family and Preventive Medicine, University of California-San Diego School of Medicine, La Jolla, San Francisco, California
    • ,
  • Douglas C. Bauer

      Affiliations

    • Department of Medicine, University of California-San Francisco, San Francisco, California
    • ,
  • Lynn M. Marshall

      Affiliations

    • Department of Orthopaedics and Rehabilitation, Oregon Health and Science University, Portland, Oregon
    • ,
  • Osteoporotic Fractures in Men Research Group

Received 24 September 2009

References 

  1. Wei JT, Calhoun E, Jacobsen SJ. Urologic Diseases in America Project: benign prostatic hyperplasia. J Urol. 2005;173:1256
  2. Boyle P, Robertson C, Mazzetta C, et al. The prevalence of lower urinary tract symptoms in men and women in four centres (The UrEpik study). BJU Int. 2003;92:409
  3. Kupelian V, Wei JT, O'Leary MP, et al. Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey. Arch Intern Med. 2006;166:2381
  4. Taylor BC, Wilt TJ, Fink HA, et al. Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS study. Urology. 2006;68:804
  5. Trueman P, Hood SC, Nayak US, et al. Prevalence of lower urinary tract symptoms and self-reported diagnosed ‘benign prostatic hyperplasia', and their effect on quality of life in a community-based survey of men in the UK. BJU Int. 1999;83:410
  6. Parsons JK, Bergstrom J, Silberstein J, et al. Prevalence and characteristics of lower urinary tract symptoms in men aged > or = 80 years. Urology. 2008;72:318
  7. Engstrom G, Henningsohn L, Steineck G, et al. Self-assessed health, sadness and happiness in relation to the total burden of symptoms from the lower urinary tract. BJU Int. 2005;95:810
  8. Engstrom G, Henningsohn L, Walker-Engstrom ML, et al. Impact on quality of life of different lower urinary tract symptoms in men measured by means of the SF 36 questionnaire. Scand J Urol Nephrol. 2006;40:485
  9. Engstrom G, Walker-Engstrom ML, Henningsohn L, et al. Prevalence of distress and symptom severity from the lower urinary tract in men: a population-based study with the DAN-PSS questionnaire. Fam Pract. 2004;21:617
  10. Parsons JK, Mougey J, Lambert L, et al. Lower urinary tract symptoms increase the risk of falls in older men. BJU Int. 2009;
  11. Hu TW, Wagner TH, Bentkover JD, et al. Estimated economic costs of overactive bladder in the United States. Urology. 2003;61:1123
  12. Saigal CS, Joyce G. Economic costs of benign prostatic hyperplasia in the private sector. J Urol. 2005;173:1309
  13. Jacobsen SJ, Girman CJ, Guess HA, et al. Natural history of prostatism: longitudinal changes in voiding symptoms in community dwelling men. J Urol. 1996;155:595
  14. Masumori N, Tsukamoto T, Rhodes T, et al. Natural history of lower urinary tract symptoms in men—result of a longitudinal community-based study in Japan. Urology. 2003;61:956
  15. Temml C, Brossner C, Schatzl G, et al. The natural history of lower urinary tract symptoms over five years. Eur Urol. 2003;43:374
  16. Sarma AV, McLaughlin JC, Jacobsen SJ, et al. Longitudinal changes in lower urinary tract symptoms among a cohort of black American men: the Flint Men's Health Study. Urology. 2004;64:959
  17. Orwoll E, Blank JB, Barrett-Connor E, et al. Design and baseline characteristics of the Osteoporotic Fractures in Men (MrOS) study—a large observational study of the determinants of fracture in older men. Contemp Clin Trials. 2005;26:569
  18. Barry MJ, Fowler FJ, O'Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia (The Measurement Committee of the American Urological Association). J Urol. 1992;148:1549
  19. Pahor M, Chrischilles EA, Guralnik JM, et al. Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol. 1994;10:405
  20. Barry MJ, Fowler FJ, O'Leary MP, et al. Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes (Measurement Committee of the American Urological Association). J Urol. 1992;148:1558
  21. McConnell JD, Roehrborn CG, Bautista OM, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med. 2003;349:2387
  22. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: diagnosis and treatment recommendations. J Urol. 2003;170:530
  23. Sarma AV, Jacobsen SJ, Girman CJ, et al. Concomitant longitudinal changes in frequency of and bother from lower urinary tract symptoms in community dwelling men. J Urol. 2002;168:1446
  24. Centers for Disease Control and Prevention. Public health and aging: trends in aging—United States and worldwide. JAMA. 2003;289:1371
  25. Rosen R, Altwein J, Boyle P, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol. 2003;44:637
  26. Kristal AR, Arnold KB, Schenk JM, et al. Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial. Am J Epidemiol. 2008;167:925
  27. Kristal AR, Arnold KB, Schenk JM, et al. Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. J Urol. 2007;177:1395
  28. Parsons JK. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems. J Urol. 2007;178:395
  29. Parsons JK, Carter HB, Partin AW, et al. Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab. 2006;91:2562
  30. Parsons JK, Kashefi C. Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. Eur Urol. 2008;53:1228

 Supported by the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute on Aging, National Center for Research Resources, National Institute of Health Roadmap for Medical Research Grants U01 AR45580, U01 AR45614, U01 AR45632, U01 AR45647, U01 AR45654, U01 AR45583, U01 AG18197, U01-AG027810 and UL1 RR024140, Department of Defense Physician Research Training Award PC073412 (JKP), and National Cancer Institute Awards CA32102 and P30 CA23100-23 (JKP).

PII: S0022-5347(10)00027-3

doi: 10.1016/j.juro.2010.01.026

The Journal of Urology
Volume 183, Issue 5 , Pages 1915-1920 , May 2010

Article Tools

* Image Usage & Resolution